This underlines the importance of regular screening for early detection of central nervous system rhabdoid tumors in patients with r22 and deletion of 22q13 (although not involving mutations of the SMARCB1 gene). The gene discussed is SMARCB1; the disease is atypical teratoid rhabdoid tumor.